{
  "$schema": "folio-library-entry/v1",
  "id": "10665-43699",
  "blocks": [
    {
      "id": "library/10665-43699/blocks/prose-sec-front-matter",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Front matter",
      "pageStart": 1,
      "pageEnd": 6,
      "target": "../sections/sec-front-matter.md",
      "narrative": null,
      "content": "WHO CASE DEFINITIONS \nOF HIV FOR SURVEILLANCE \nAND REVISED CLINICAL \nSTAGING AND IMMUNOLOGICAL \nCLASSIFICATION \nOF HIV-RELATED DISEASE \nIN ADULTS AND CHILDREN\nStrengthening health services to fight HIV/AIDS\nHIV/AIDS Programme\nWHO Library Cataloguing-in-Publication Data\nWHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related \ndisease in adults and children.\n1.HIV infections - diagnosis. 2.HIV infections - classification. 3.Disease progression. 4.Epidemiologic surveillance - \nstandards. 5.Disease notification - standards. I.World",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The title, cataloguing and copyright pages of WHO's 2007 publication on HIV case definitions for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children, with ISBN, rights notices and contents.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-43699/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Abbreviations",
      "pageStart": 6,
      "pageEnd": 7,
      "target": "../sections/sec-000-abbreviations.md",
      "narrative": null,
      "content": "AIDS \nacquired immunodeficiency syndrome\nART \nantiretroviral therapy\nCD4+ \nT-lymphocyte bearing CD4 receptor\nCDC  \nUnited States Centers for Disease Control and Prevention\nDNA \ndeoxyribonucleic acid\nHIV \nhuman immunodeficiency virus\nPMTCT \nprevention of mother to child transmission ( of HIV)\nRNA \nribonucleic acid\nWHO \nWorld Health Organization\nEIA \nEnzyme Immunoassay\nELISA \nEnzyme-Linked immunosorbent assay\nS/R Test \nSimple or Rapid HIV antibody test",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A list of abbreviations used in the HIV case definitions and staging publication.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-43699/blocks/prose-sec-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Introduction",
      "pageStart": 7,
      "pageEnd": 8,
      "target": "../sections/sec-001-introduction.md",
      "narrative": null,
      "content": "With a view to facilitating the scaling up of access to antiretroviral therapy, and in line with a \npublic health approach\u0004, this publication outlines recent revisions WHO has made to case \ndefinitions for surveillance of HIV and the clinical and the immunological classification for HIV-\nrelated disease. HIV case definitions are defined and harmonized with the clinical staging and \nimmunological classifications to facilitate improved HIV-related surveillance, to better track the \nincidence, prevalence and treatment burden of HIV infection and to plan appropriate public \nhealth responses. The r",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The introduction explains that WHO revised its HIV case definitions for surveillance and harmonized them with clinical staging and immunological classification, to support scaling up antiretroviral therapy and track the HIV epidemic. It notes the revisions came from regional consultations in 2004–2005 and a consensus meeting in 2006, and that AIDS reporting alone no longer gives reliable data now that treatment delays AIDS.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-43699/blocks/prose-sec-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Background",
      "pageStart": 8,
      "pageEnd": 9,
      "target": "../sections/sec-002-background.md",
      "narrative": null,
      "content": "(Bangui definition) [1] to report AIDS cases in resource-constrained settings [2, 3]. The definition \nwas formalized in 1986 and modified in 1989 (for adults and adolescents only) to include \nserological HIV testing and then modified again in 1994 to accommodate 1993 revisions to \nEuropean and United States Centers for Disease Control and Prevention definitions [3-12]. \nEuropean and United States Centers for Disease Control and Prevention definitions include \nspecific case definitions for children. Studies in African settings [13-15] suggest that the original \nWHO clinical case definitions for",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Traces the history of WHO's AIDS case definitions from the 1985 Bangui definition through revisions in 1986, 1989 and 1994, noting weak performance of the paediatric definition. It explains that AIDS reporting in low- and middle-income countries has been incomplete, while treatment has reduced new AIDS cases and deaths where coverage is high.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-43699/blocks/prose-sec-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Surveillance and case reporting for HIV",
      "pageStart": 9,
      "pageEnd": 10,
      "target": "../sections/sec-003-surveillance-and-case-reporting-for-hiv.md",
      "narrative": null,
      "content": "HIV counselling and testing has led to an increase in the numbers of adults and children being \ntested and diagnosed with HIV infection. Accurate data are needed on adults and children \ndiagnosed with HIV infection to facilitate estimation of the treatment and care burden, to plan for \neffective prevention and care interventions and assess care interventions. WHO therefore \nrecommends that countries consider conducting reporting of newly diagnosed cases of HIV \ninfection in adults and children (Box 1). The requirements for the confidentiality and security of \nHIV surveillance data are the same",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Recommends that countries report newly diagnosed HIV infection in adults and children, with the same confidentiality as AIDS reporting and with providers initiating reports. It also sets the age definitions used for children, adults, youth and infants.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-43699/blocks/prose-sec-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "WHO case definition for HIV infection",
      "pageStart": 10,
      "pageEnd": 11,
      "target": "../sections/sec-004-who-case-definition-for-hiv-infection.md",
      "narrative": null,
      "content": "To facilitate the reporting of HIV infection, WHO recommends the following:\nHIV cases diagnosed and not previously reported in each country should be reported according \nto a standard national case definition. A case of HIV infection is defined as an individual with HIV \ninfection irrespective of clinical stage (including severe or stage 4 clinical disease, also known \nas AIDS) confirmed by laboratory criteria according to country definitions and requirements. \nCountries should develop and regularly review their testing algorithms for diagnostic and \nsurveillance purposes.\u0004 WHO provides a simp",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out WHO's recommendation that new HIV cases be reported using a standard national case definition confirmed by laboratory criteria at any clinical stage. Box 1 gives the diagnostic criteria, using two antibody tests or virological tests for people aged 18 months or older and virological tests for younger children because maternal antibodies persist.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-43699/blocks/prose-sec-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "WHO case definition for advanced HIV (infection or disease) (including AIDS)",
      "pageStart": 11,
      "pageEnd": 12,
      "target": "../sections/sec-005-who-case-definition-for-advanced-hiv-infection-o.md",
      "narrative": null,
      "content": "(infection or disease) (including AIDS) for reporting:\nCases diagnosed with advanced HIV infection (including AIDS) not previously reported should \nbe reported according to a standard case definition. Advanced HIV infection is diagnosed based \non clinical or immunological (CD4) criteria among people with confirmed HIV infection (Box 2).\nBox 2.\t\nCriteria for diagnosis of advanced HIV (including AIDSa)  \nfor reporting for adults and children:\n•\t Clinical criteria for diagnosis of advanced HIV in adults and children \nwith confirmed HIV infection:\nPresumptive or definitive diagnosis of any stage 3",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines advanced HIV infection, including AIDS, for reporting, based on stage 3 or 4 clinical conditions or CD4 thresholds by age. A footnote gives the stricter definition of AIDS, and the text states that separate AIDS case reporting is no longer required where HIV and advanced HIV are reported.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-43699/blocks/prose-sec-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Primary HIV infection",
      "pageStart": 12,
      "pageEnd": 13,
      "target": "../sections/sec-006-primary-hiv-infection.md",
      "narrative": null,
      "content": "where recognized and documented, is useful and should be encouraged. The United States \nCenters for Disease Control and Prevention (CDC) are expected to develop a case definition for \nreporting primary HIV infection. Primary HIV infection can be recognized in infants, children, \nadolescents and adults; it can be asymptomatic or be associated with features of an acute \nretroviral syndrome of variable severity [16-21]. Primary infection usually presents as an acute \nfebrile illness 2–4 weeks postexposure, often with lymphadenopathy, pharyngitis, maculopapular \nrash, orogenital ulcers and meningo",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes primary HIV infection, which may be silent or cause an acute febrile illness with rash, sore throat and swollen glands a few weeks after exposure, and how it can be identified. It reviews the history of WHO clinical staging, explains that the new staging is harmonized across ages, and proposes using new or recurrent staging events to assess people on antiretroviral therapy.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-43699/blocks/prose-sec-007",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Clinical and immunological classification for HIV and related disease",
      "pageStart": 13,
      "pageEnd": 14,
      "target": "../sections/sec-007-clinical-and-immunological-classification-for-hi.md",
      "narrative": null,
      "content": "of HIV and related disease",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A heading fragment for the section on clinical and immunological classification of HIV.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-43699/blocks/prose-sec-008",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Table 1. WHO clinical classification of established HIV infection",
      "pageStart": 14,
      "pageEnd": 17,
      "target": "../sections/sec-008-table-1-who-clinical-classification-of-establish.md",
      "narrative": null,
      "content": "HIV-associated symptoms\nWHO clinical stage\nAsymptomatic\n1\nMild symptoms \n2\nAdvanced symptoms \n3\nSevere symptoms \n4\nClinical assessment of people receiving antiretroviral therapy\nTreatment with potent and effective antiretroviral therapy regimens can reverse and improve \nclinical status in keeping with immune recovery and suppression of viral load [37, 39-41]. New or \nrecurrent clinical staging events once people are receiving antiretroviral therapy for more than 24 \nweeks may be used to guide decision-making, particularly when the CD4 count is not available. \nIt is assumed that the clinical st",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives the four WHO clinical stages from asymptomatic to severe and explains how staging events can guide decisions for people on antiretroviral therapy after 24 weeks, when early events may reflect immune reconstitution. It describes CD4 cell counts and percentages as the standard measure of HIV-related immune deficiency. It notes that healthy infants have much higher CD4 values than adults, which fall with age.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-43699/blocks/table-001",
      "types": [
        "folio-assistant-core:Table",
        "doco:Table"
      ],
      "kind": "table",
      "title": "Table 1. WHO clinical staging of established HIV infection",
      "pageStart": 14,
      "pageEnd": 14,
      "target": "../tables/table-1.csv",
      "narrative": "draft",
      "content": "The table maps the severity of HIV-associated symptoms (asymptomatic, mild, advanced, severe) to WHO clinical stages 1 to 4 for established HIV infection.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-43699/blocks/prose-sec-009",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Table 2. WHO immunological classification for established HIV infection",
      "pageStart": 17,
      "pageEnd": 21,
      "target": "../sections/sec-009-table-2-who-immunological-classification-for-est.md",
      "narrative": null,
      "content": "HIV-associated \nimmunodeficiency\nAge-related CD4 values\n<11 \nmonths\n(%CD4+)\n12–35 \nmonths\n(%CD4+)\n36–59 \nmonths\n(%CD4+)\n>5 years \n(absolute \nnumber \nper mm3 or \n%CD4+)\nNone or not significant\n>35\n>30\n>25\n> 500\nMild\n30–35\n25–30\n20–25\n350−499\nAdvanced\n25–29\n20–24\n15−19\n200−349\nSevere \n<25\n<20\n<15\n<200 or <15% \nTable 3.\t WHO clinical staging of HIV/AIDS for adults and adolescents  \nwith confirmed HIV infection\u0004\nClinical stage 1\nAsymptomatic\nPersistent generalized lymphadenopathy\nClinical stage 2\nModerate unexplained weight loss  \n(<10% of presumed or measured body weight)I\nRecurrent respiratory t",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Table 2 gives the WHO immunological classification of HIV-associated immunodeficiency by age-specific CD4 values. Table 3 lists the clinical conditions that define stages 1 to 4 in adults and adolescents, from persistent lymphadenopathy to wasting, tuberculosis, Kaposi's sarcoma and other opportunistic infections. The block goes on to the corresponding staging for children.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-43699/blocks/table-002",
      "types": [
        "folio-assistant-core:Table",
        "doco:Table"
      ],
      "kind": "table",
      "title": "Table 2. WHO immunological classification for established HIV infection",
      "pageStart": 17,
      "pageEnd": 17,
      "target": "../tables/table-2.csv",
      "narrative": "draft",
      "content": "The table classifies HIV-associated immunodeficiency as none or not significant, mild, advanced or severe according to age-related CD4 values. Columns give %CD4+ thresholds for children under 11 months, 12–35 months and 36–59 months, and absolute CD4 count per mm³ or %CD4+ for those over 5 years.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-43699/blocks/table-003",
      "types": [
        "folio-assistant-core:Table",
        "doco:Table"
      ],
      "kind": "table",
      "title": "Table 3. WHO clinical staging of HIV/AIDS for adults and adolescents with confirmed HIV infectionⁱ",
      "pageStart": 17,
      "pageEnd": 18,
      "target": "../tables/table-3.csv",
      "narrative": "draft",
      "content": "The table lists the clinical conditions that define WHO clinical stages 1 to 4 of HIV/AIDS in adults and adolescents with confirmed HIV infection; each stage heading is followed by its conditions.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-43699/blocks/table-004",
      "types": [
        "folio-assistant-core:Table",
        "doco:Table"
      ],
      "kind": "table",
      "title": "Table 4. WHO clinical staging of HIV/AIDS for children with confirmed HIV infection",
      "pageStart": 19,
      "pageEnd": 20,
      "target": "../tables/table-4.csv",
      "narrative": "draft",
      "content": "The table lists the clinical conditions that define WHO clinical stages 1 to 4 of HIV/AIDS in children with confirmed HIV infection; each stage heading is followed by its conditions.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-43699/blocks/prose-sec-010",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "clinical events among adults (15 years or older) and among children (younger than 15 years) with confirmed HIV infection",
      "pageStart": 21,
      "pageEnd": 41,
      "target": "../sections/sec-010-clinical-events-among-adults-15-years-or-older-a.md",
      "narrative": null,
      "content": "than 15 years) with confirmed HIV infection\nClinical event\nClinical diagnosis \nDefinitive diagnosis \nRecurrent oral ulceration \n(two or more episodes in \nlast six months).\nAphthous ulceration, \ntypically painful with a halo \nof inflammation and a yellow-\ngrey pseudomembrane.\nClinical diagnosis. \nPapular pruritic eruption.\nPapular pruritic lesions, \noften with marked post-\ninflammatory pigmentation.\nClinical diagnosis.\nSeborrhoeic dermatitis.\nItchy scaly skin condition, \nparticularly affecting hairy \nareas (scalp, axillae, upper \ntrunk and groin).\nClinical diagnosis.\nFungal nail infection.\nParo",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "An annex table giving clinical and definitive criteria for diagnosing each HIV staging event in adults and in children under 15 years. Entries range from oral ulceration, skin conditions and fungal nail infections to severe weight loss, chronic diarrhoea and oesophageal candidiasis. Stage 4 conditions such as extrapulmonary tuberculosis and visceral herpes are also covered. The end covers disseminated fungal and mycobacterial infections, which need laboratory confirmation.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-43699/blocks/prose-sec-011",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Presumptive diagnosis of severe HIV disease among HIV-seropositive HIV-exposed children",
      "pageStart": 41,
      "pageEnd": 42,
      "target": "../sections/sec-011-annex-2-presumptive-diagnosis-of-severe-hiv-dise.md",
      "narrative": null,
      "content": "• the infant is confirmed as HIV antibody-positive\nand\n• diagnosis of any AIDS-indicator condition(s)a can be made\nor\n• the infant is symptomatic with two or more of the following:\n oral thrushb;\n severe pneumoniab;\n severe sepsisb.\nOther factors that support the diagnosis of severe HIV disease in an  \nHIV-seropositive infant include:\n• recent HIV-related maternal death or advanced HIV disease in the mother;\n• CD4 <20%.c\nConfirmation of the diagnosis of HIV infection should be sought as soon as possible.\na \nAIDS indicator conditions include some but not all HIV clinical stage 4 conditions seen",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Annex 2 sets out criteria for a presumptive diagnosis of severe HIV disease in HIV antibody-positive infants under 18 months, based on AIDS-indicator conditions or a combination of thrush, severe pneumonia and severe sepsis. It notes supporting factors such as maternal death or low CD4 and urges confirmation as soon as possible.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-43699/blocks/prose-sec-012",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 42,
      "pageEnd": 52,
      "target": "../sections/sec-012-references.md",
      "narrative": null,
      "content": "World Health Organization. Workshop on AIDS in Africa 1986(WHO/CDS/AIDS.85.1).\n[2] \nWorld Health Organization. Acquired Immunodeficiency syndrome (AIDS) WHO/CDC case \ndefinition for surveillance Weekly Epidemiological Record. 1986 7 March (10).\n[3] \nWorld Health Organization. Acquired Immunodeficiency Syndrome. 1987 Revision of WHO/\nCDC case definition for AIDS. Weekly Epidemiological Record. 1988 1-8 January;63:1-8.\n[4] \nRevision of the CDC surveillance case definition for acquired immunodeficiency syndrome. \nCouncil of State and Territorial Epidemiologists; AIDS Program, Center for Infectiou",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A reference list citing mainly WHO and US CDC AIDS case definitions and studies on HIV progression and staging; the extracted text ends in long runs of dots.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    }
  ]
}
